Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Cardiovascular Risk in Patients With Rheumatoid Arthritis: A Cross-Sectional Study of Chinese Cohort

BackgroundThe nomenclature from non-alcoholic fatty liver disease (NAFLD) to metabolic dysfunction-associated fatty liver disease (MAFLD) is considered to identify more cardiovascular disease (CVD) risks in the general population. Patients with rheumatoid arthritis (RA) carry an excess risk for CVD....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Yao-Wei Zou, Qian-Hua Li, Jing-Wei Gao, Jie Pan, Jian-Da Ma, Le-Feng Chen, Jian-Zi Lin, Ying-Qian Mo, Xue-Pei Zhang, Pin-Ming Liu, Lie Dai
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2022-05-01
Schriftenreihe:Frontiers in Cardiovascular Medicine
Schlagworte:
cardiovascular disease
rheumatoid arthritis
metabolic dysfunction-associated fatty liver disease
non-alcoholic fatty liver disease
inflammation
Online Zugang:https://www.frontiersin.org/articles/10.3389/fcvm.2022.884636/full
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge